Skip to content
Screener

EPS (Diluted) at other companies

Tenet Healthcare logo
Tenet HealthcareTHC
$9.84+213%
Mannkind logo
MannkindMNKD
-$0.06—
United Therapeutics logo
United TherapeuticsUTHR
$7.27+13.4%
TBP
TBPHTBPH
-$0.11-110%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
-$1.06-783%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$0.28+75.0%

Other financials

Income statement

See full
Revenue$171.7M+1,843%
Gross profit$1.6M+6.5%
Operating income$85.5M+328%
Net income$74.7M+280%

Balance sheet

See full
Cash & equivalents$284.2M+63.9%
Total debt$6.8M+0.3%
Total equity$195.1M+1,185%
Total assets$521.9M+103%

Cash flow

See full
Operating cash flow$80.2M+303%
CapEx$11.2M+963%
Free cash flow$69.0M+270%

Valuation

See full
Market cap$2.51B+32.9%
Enterprise value$2.23B+28.4%
P/E30.4×—
P/S5.6×-21.7×

Profitability

See full
Gross margin58.1%-18.7pp
Operating margin-155%-68.1pp
Net margin-176.2%-76.4pp
FCF margin-150.7%-64.4pp

Returns & leverage

See full
Return on equity-181%+57.4pp
Debt / equity0×-0.4×
Current ratio2.3×-0.2×

Where this comes from

Reported directly by Liquidia Corporation in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: Liquidia Corporation’s 10-Q, filed August 12, 2026.

Filed
Aug 12, 2026, 6:45 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-094410
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Total other expense, net(3,820)(4,074)(8,542)(7,016)
Income (loss) before income taxes81,697(41,579)138,479(79,946)
Income tax expense6,975—10,895—
Net income (loss) and comprehensive income (loss)$74,722$(41,579)$127,584$(79,946)
Net income (loss) per common share, basic$0.84$(0.49)$1.44$(0.94)
Net income (loss) per common share, diluted$0.74$(0.49)$1.26$(0.94)
Weighted average common shares outstanding, basic88,887,74485,588,10888,449,42785,381,563
Weighted average common shares outstanding, diluted101,397,02885,588,108101,258,42685,381,563

Item 1. Condensed Financial Statements (unaudited)

FAQ

What is Liquidia Corporation's EPS (diluted)?
Liquidia Corporation (LQDA) reported EPS (diluted) of $0.74 in Q2 2026.
How has Liquidia Corporation's EPS (diluted) changed year-over-year?
Liquidia Corporation's EPS (diluted) increased by 251.0% year-over-year, from -$0.49 to $0.74.
What is the long-term trend for Liquidia Corporation's EPS (diluted)?
Over 3 years (2021 to 2024), Liquidia Corporation's EPS (diluted) has grown at a 32.2% compound annual growth rate (CAGR), from -$0.71 to -$1.64.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about Liquidia Corporation's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude